0001562180-22-006665.txt : 20220914
0001562180-22-006665.hdr.sgml : 20220914
20220914180431
ACCESSION NUMBER: 0001562180-22-006665
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220912
FILED AS OF DATE: 20220914
DATE AS OF CHANGE: 20220914
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linetsky David
CENTRAL INDEX KEY: 0001776729
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38977
FILM NUMBER: 221243935
MAIL ADDRESS:
STREET 1: C/O PHREESIA, INC.
STREET 2: 432 PARK AVENUE S., 12TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Phreesia, Inc.
CENTRAL INDEX KEY: 0001412408
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0131
BUSINESS ADDRESS:
STREET 1: 1521 CONCORD PIKE
STREET 2: SUITE 301 PMB 221
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: 888-654-7473
MAIL ADDRESS:
STREET 1: 1521 CONCORD PIKE
STREET 2: SUITE 301 PMB 221
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Phreesia Inc
DATE OF NAME CHANGE: 20070914
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-09-12
false
0001412408
Phreesia, Inc.
PHR
0001776729
Linetsky David
C/O PHREESIA, INC.
1521 CONCORD PIKE, SUITE 301 PMB 221
WILMINGTON
DE
19803
false
true
false
false
SVP, Life Sciences
Common Stock
2022-09-12
4
A
false
1589.00
A
226074.00
D
Common Stock
2022-09-12
4
F
false
626.00
29.19
D
225448.00
D
Common Stock
5683.00
I
By spouse
Stock Option (Right to buy)
4.71
2028-10-24
Common Stock
285.00
285.00
I
By spouse
Represents Restricted Stock Units ("RSUs") that were fully vested as of the grant date. These RSUs represent awards received in lieu of 50% of the Reporting Person's cash bonus earned for the first half of the fiscal year ending January 31, 2023 under the Issuer's Senior Executive Cash Incentive Bonus Plan. The Reporting Person elected to convert such portion of his earned cash bonus into RSUs representing 115% of such amount. The number of RSUs granted are based on a per share value of $29.19, the closing price of the Issuer's common stock on September 12, 2022.
Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the settlement of fully vested RSUs granted on September 12, 2022 and does not represent a sale by the Reporting Person.
228 of the shares subject to this option are vested as of the date hereof, and the remaining shares will vest and become exercisable in two equal installments on September 25, 2022 and October 25, 2022.
/s/ Allison Hoffman by Power of Attorney for David Linetsky
2022-09-14